%0 Journal Article
%T 房颤导管消融成功后抗凝<br>Anticoagulation after Successful Catheter Ablation of Atrial Fibrillation
%A 王丽娟
%A 汪敏
%A 双东思
%J Advances in Clinical Medicine
%P 1892-1898
%@ 2161-8720
%D 2020
%I Hans Publishing
%R 10.12677/ACM.2020.109284
%X <div style=\"text-align:justify;\">
	房颤患者有发生脑血管栓塞事件(cerebrovascular embolic events, CVEs)的风险，包括卒中和短暂性脑缺血发作。口服抗凝药物治疗(oral anticoagulation therapy, OAT)可以有效地预防CVE，而导管消融(catheter ablation, CA)治疗房颤已成为部分患者最有效的节律控制策略。尽管有回顾性研究认为通过CA消除房颤或减轻房颤负担可能会显著降低卒中风险，然而在导管消融成功后是否可以安全地停止OAT仍然是一个有争议的话题。<br />
Patients with atrial fibrillation are at risk for thromboembolic events (cerebrovascularembolicevents, CVEs), including stroke and transient ischemic attacks. Anticoagulant therapy (oralanticoagulation therapy, OAT) can effectively prevent CVE, catheter ablation (catheterablation, CA) in the treatment of atrial fibrillation has become the most effective rhythm control strategy for some patients. Although retrospective studies have suggested that eliminating atrial fibrillation or reducing the burden of atrial fibrillation through CA may significantly reduce stroke risk, whether OAT can be stopped safely after successful catheter ablation is still a controversial topic.
</div>
%K 心房颤动，导管消融，口服抗凝停止，卒中<br>Atrial Fibrillation
%K Catheter Ablation
%K Anticoagulant
%K Stroke
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=37531